Xenetic Biosciences, Inc. (XBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.69M |
| Enterprise Value | -4.19M |
| P/E Ratio | -3.02 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 2.52 |
| Price/Book Ratio | 1.36 |
| Enterprise/Revenue | 0.54 |
| Enterprise/EBITDA | -0.71 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.76 |
| Operating Margin | -0.81 |
| Return On Assets | -0.36 |
| Return On Equity | -0.41 |
| Revenue | 2.98M |
| Revenue/Share | 1.42 |
| Gross Profit | 2.98M |
| EBITDA | -2.68M |
| Net Income | -2.68M |
| Diluted EPS | -1.58 |
| Total Cash | 6.47M |
| Total Cash/Share | 2.82 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.43 |
| Book Value Per Share | 2.65 |
| 52-Week Change | 25.52 |
| 52-Week High | 13.93 |
| 52-Week Low | 1.9 |
| Moving Average 50 Days | 2.92 |
| Moving Average 200 Days | 2.73 |
| Average Volume | 34,761 |
| Shares Outstanding | 2.29M |
| % Held by Institutions | 3.8 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | May 15, 2023 |